Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 30% ± 13% | |
vein endothelial cell | 10 studies | 33% ± 16% | |
endothelial cell of artery | 9 studies | 31% ± 18% | |
capillary endothelial cell | 9 studies | 34% ± 16% | |
endothelial cell of vascular tree | 6 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of SOX7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 1891.63 | 1426 / 1445 | 98% | 20.02 | 179 / 183 |
thymus | 99% | 1277.76 | 645 / 653 | 81% | 5.34 | 492 / 605 |
breast | 100% | 1853.06 | 457 / 459 | 79% | 4.44 | 888 / 1118 |
lung | 100% | 3567.95 | 577 / 578 | 77% | 7.87 | 894 / 1155 |
uterus | 96% | 786.39 | 163 / 170 | 80% | 18.28 | 369 / 459 |
prostate | 95% | 911.99 | 232 / 245 | 80% | 4.38 | 402 / 502 |
adrenal gland | 74% | 473.81 | 192 / 258 | 79% | 12.26 | 182 / 230 |
bladder | 95% | 700.48 | 20 / 21 | 58% | 6.42 | 292 / 504 |
kidney | 90% | 634.82 | 80 / 89 | 62% | 5.76 | 563 / 901 |
stomach | 63% | 395.67 | 227 / 359 | 66% | 4.18 | 188 / 286 |
intestine | 79% | 577.96 | 766 / 966 | 46% | 2.73 | 242 / 527 |
skin | 72% | 1760.45 | 1305 / 1809 | 51% | 2.82 | 240 / 472 |
brain | 63% | 333.69 | 1664 / 2642 | 50% | 1.55 | 352 / 705 |
pancreas | 23% | 88.48 | 76 / 328 | 89% | 8.35 | 158 / 178 |
adipose | 100% | 2760.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1245.60 | 852 / 861 | 0% | 0 | 0 / 0 |
muscle | 94% | 869.53 | 751 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 15.48 | 42 / 45 |
liver | 38% | 183.84 | 85 / 226 | 49% | 2.07 | 199 / 406 |
spleen | 74% | 327.18 | 179 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 69% | 571.99 | 922 / 1335 | 0% | 0 | 0 / 0 |
ovary | 23% | 119.42 | 42 / 180 | 25% | 1.01 | 107 / 430 |
lymph node | 0% | 0 | 0 / 0 | 31% | 1.38 | 9 / 29 |
eye | 0% | 0 | 0 / 0 | 13% | 0.30 | 10 / 80 |
peripheral blood | 1% | 3.74 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001706 | Biological process | endoderm formation |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0030154 | Biological process | cell differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
Gene name | SOX7 |
Protein name | Transcription factor SOX-7 |
Synonyms | |
Description | FUNCTION: Binds to and activates the CDH5 promoter, hence plays a role in the transcriptional regulation of genes expressed in the hemogenic endothelium and blocks further differentiation into blood precursors (By similarity). May be required for the survival of both hematopoietic and endothelial precursors during specification (By similarity). Competes with GATA4 for binding and activation of the FGF3 promoter (By similarity). Represses Wnt/beta-catenin-stimulated transcription, probably by targeting CTNNB1 to proteasomal degradation. Binds the DNA sequence 5'-AACAAT-3'. . |
Accessions | Q9BT81 ENST00000304501.2 [Q9BT81-1] ENST00000646538.2 [Q9BT81-1] |